FF Rollerskis AS – Bringing the Real Skiing Feeling to Asphalt FF Rollerskis AS is a Norwegian sports tech company redefining how athletes train off-season by designing and manufacturing world-leading roller skis. Founded by Henrik Lindhagen — skier, inventor, and innovator — our goal is simple: recreate the authentic feeling of skiing on snow, even on asphalt. Traditional roller skis are often stiff, unforgiving, and prone to cause strain or injury due to excessive vibration and poor flexibility. At FF Rollerskis, we’ve reengineered the roller ski from the ground up. Our unique floating fork suspension system and custom-developed rubber compounds drastically reduce vibration while preserving the natural flex and responsiveness of winter skis. The result? Roller skis that feel like the real thing. Our products include the FF V Pro Classic and FF Pro Skate, both equipped with V-groove wheels that enhance directional stability and simulate the resistance of groomed ski tracks. These wheels — along with advanced frame engineering — offer unparalleled ski feel, helping athletes maintain and refine technique throughout the off-season. Our Active series and Junior models make the FF experience accessible for younger athletes and recreational users alike. What sets FF Rollerskis apart: True ski feel on asphalt, with flex and vibration damping unmatched in the market. V-groove wheels that guide the ski naturally, improve control, and make skiing safer — especially for classic technique. Used by top athletes, including members of the Norwegian National Cross-Country Team and elite junior skiers. Only FIS-approved rollerski brand globally. Developed and tested in Norway — under real-world Nordic conditions. We’re committed to environmental responsibility and local production. All development and testing is done in Norway, and our goal is to bring the full manufacturing process home, enabling shorter supply chains, lower emissions, and job creation. Beyond just equipment, FF Rollerskis is building a movement. We offer a 100% satisfaction guarantee, provide free lifetime checkups (only pay for parts), and work closely with ambassadors and users to continuously improve our designs. Our customer base spans from beginners seeking safe, stable skis — to elite athletes demanding the highest performance. Whether you’re training for the World Cup, prepping for your first ski marathon, or looking for a smooth ride on summer roads, FF Rollerskis delivers the experience you’ve been missing. It’s not just about equipment — it’s about keeping the skiing spirit alive all year long. Visit us at www.ffskis.com Learn more: www.ffskis.com Learn more: ffskis.com Mail: henrik@ffskis.com Mobile: +47 95 88 70 70

Bransjeekspert Yngvar Andreassen hadde tilbake i 2017 en teori om at man ved å digitalisere gjestereisen på restaurant kunne øke omsetningen med 20 %, og redusere kostnadene tilsvarende. Dette var som musikk i ørene på Jørn Bertelsen som oppnådde denne type resultater i et pilotprosjekt på Lekter´n på Aker Brygge våren 2018 – og som har analysert tall i bransjen i over 20 år. Det er en etablert sannhet at det er irriterende for gjester å vente på å bestille, betale og påkalle oppmerksomheten til servitørene. Payrest er en løsning for dette. Det som ikke like kjent at mange restauranter sliter med et høyt kostnadsnivå, og noe av grunnen til dette er at personalet bruker opptil 30% av arbeidstiden sin på å betjene systemer. Vi løser dette gjennom Payrest ved at gjestene selv registrerer bestillingen og betalingen på sin egen mobiltelefon. Dette gir deg som restaurantdriver muligheten til å bruke mer tid på servering og service! Payrest skal levere fremtidens løsning for servicebransjen – og har fokus på å levere en bedre gjesteopplevelse. Sammen med innovasjonsselskapet Norsentio driver Yngvar og Jørn, Payrest Norge. Løsningen er klar til å gi solhungrige og corona-leie nordmenn en trygg og effektiv restaurantopplevelse sommeren 2021! Gjennom 2018 og 2019 ble det investert 10 millioner i løsningen, og brukerne er så langt godt fornøyde med det som er levert – men vi gir oss ikke med det. Selskapet backes også av Innovasjon Norge og Skattefunnordningen.

ExperWELL AS was established in 2016 by an innovative group of Ph.D. scientists and engineering professionals in resin technology and services for the oil and gas industry. Our focus is to be reliable, competent, innovative, and flexible. Our head office is in Norway. ExperWELL® today has different partners and agents in different countries. Our vision is to be the world leader in resin products & services for downhole applications in the oil and gas industry. Our mission is to provide eternal good barriers from innovating, environment-friendly resin. ExperWELL®’s strength lies in its experienced Ph.D. scientists who have many years of experience in resin product development and realization, as well as its experienced professional engineers in an understanding of oil & gas reservoir description and flow dynamics leading to individual well and field production performance. We are proud of what we do and strive for success with our passionate team of dedicated people. ExperWELL®’s Top Management Team always knows that the highest importance is the environment as well as the Health and Safety of our staff, persons working with our products and on our behalf, and anyone else who may be related to our operations. That is why our product development and realization is focused on GREEN and environment-friendly products which eliminate adverse effects on the environment and personnel. The Company aims to develop our proprietary main products which are safe to use as household goods.

GI ALLE MULIGHET TIL Å INVESTERE I VEKSTSELSKAPER GJENNOM AKSJEKJØP. Folkeinvest AS ønsker med webtjenesten folkeinvest.no å demokratisere investering i oppstartsselskaper.Emisjonsprosessen har frem til nå være komplisert både for selskapet og de som vil investere. Derfor har slike investeringer vanligvis kun blitt tilbudt bekjente av selskapet og profesjonelle investorer.Folkefinansiering med lave minstebeløp og en lettfattelig webtjeneste gir alle mulighet til å investere.Å investere i oppstartsselskaper er forbundet med risiko for at investeringen kan gå tapt. Mange selskaper overlever ikke sine fem første år. Men det er også i den fasen at verdistigningen kan bli høy. Vi mener at denne investeringsmuligheten bør være tilgjengelig for alle.Folkeinvest.no har åpne investorlister, diskusjonsforum og krav til dokumentasjon som gjør at aksjekjøpere er godt rustet til å ta investeringsbesluttninger.

Vi bistår våre kunder med markedsstrategier både digitalt og analogt. Zebra Media er et nytenkende og kreativt mediebyrå som har spesialisert seg på strategier, kreativt design og innovativ markedsteknologi. Zebra Media er et medie- og reklamebyrå med fokus på å hjelpe bedrifter å finne de rette løsningene innen digital markedsføring og grafisk design.

Speak Norsk is an ambitious team that started with one goal in mind – to make expats fluent in Norwegian! We are passionate about language-learning and bringing to Norway a new, innovative way of teaching Norwegian. Since the beginning, we have been known for our interactive conversation-focused classes, own-written books, and something that it´s not quite common for other schools – a personal approach and a customized offer for each one of our students. Meet our passionate and united team of Speak Norsk school!

Movel AS provides support and invoicing services for AC charging systems. We specialize in systems that provide normal charging for long-term and overnight parking. Movel wants to contribute to a more environmentally friendly life. Therefore, all power in Movel's charging systems provides renewable energy.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

LifeTools AS develops digital tools for people with complex needs within the fields of communication, cognition, and challenged behavior. We put the user first and develop dynamic systems with high flexibility based on the unique user's needs. The network around the user will have digital tools to observe, build and publish expressions, routines, and activities into our systems, and use this information back into the interaction with the user. This gives a better foundation in communication and helps increase the quality of life for the user. Our philosophy is to use "everyday technology" such as tablets/phones and cloud-based solutions and develop highly intuitive and dynamic tools for the network. Users (people with special and complex needs) therefore do not need to acquire skills or knowledge in order to use our systems. This makes it easier for those who have great cognitive challenges to make use of our technological solutions.

Vi tør å tenke nytt i en bransje som er preget av umoderne arbeidsformer, og kombinerer tung juridisk kompetanse med markedsledende teknologi. LIGL ble startet for å utfordre den konservative advokatbransjen, og bygger på tre grunnleggende prinsipper, kompetanse, kultur og teknologi – vårt DNA. Gjennom innovativ bruk av teknologi, en moderne forretningsmodell og et unikt arbeidsmiljø, vil vi skape et reelt, effektivt og eksklusivt alternativ til de største advokatfirmaene i Norge. Vi vet at dette vil og må ta tid, men vi vet også at det er denne veien bransjen vil utvikle seg – og vi ønsker å være i forkant. LIGL består av topp kvalifiserte forretningsadvokater med lang fartstid, solid faglig ekspertise og entusiasme for den jobben de gjør. Flere av firmaets advokater kommer fra ledende partnerstillinger i landets største advokatfirmaer. Kundene våre er norske og internasjonale virksomheter. Vi bistår alt fra gründervirksomheter i oppstart, til store selskaper med en lang historie å se tilbake på. Vi tar også oppdrag for privatpersoner innenfor utvalgte rettsområder. Firmaet leverer advokattjenester innen følgende fagområder: - Corporate, strategisk selskapsrettslig rådgivning - Rekonstruksjon & insolvens - Immaterialrett & teknologi - Fast eiendom - Skatt - Tvisteløsning Firmaets advokater er dyktige tverrfaglige forretningsadvokater, og firmaet tar derfor også oppdrag innenfor andre fagområder som naturlig leveres av et kompetent forretningsadvokatfirma, som arbeidsrett, kontraktsrett, entreprise etc.

Our ambition is to offer a product that protects against virus infections in the upper airways, and helps to maintain a healthy nose Keeping the mucous membranes moist is by many ENT-doctors seen as one of the most important measures you can take to prevent viruses from entering through the nasal mucosa, and in general maintaining a healthy nose.

In the autumn of 2016 was CSI Marine Cleaning AS [CSI] established and included in Validé's incubation program with our idea for a ship hull cleaner and cleaning of other structures submerges in the sea. CSI's idea and goal with this unit are to collect 100% of all bio-marine fouling that comes off of the surface while cleaning. The collected fouling will then be rendered harmless by killing all bio-marine life that is collected before returning it back to the sea. As of date, there is no ship hull cleaner that can document 100% collection of the fouling. Competitive ship hull cleaners vary in the collection of the bio-marine fouling from 25μm and upwards. The need for collection is as low as 2μm according to a study.CSI has secured letters of intent with Yanmar Co. LTD., Østerbø Maskin AS, and Optimarin AS with regard to the development of the collection system and ship hull cleaning unit. CSI has also in the letter of intent with Optimarin AS secured exclusive rights for use of their technology in our line of business. Furthermore, CSI has secured letters of intent with Teekay Shipping Norge AS and Transpetrol Tm AS stating their interest in the finalized product. They may intend to use the cleaning service if the product function as described and the service has competitive pricing.  Information about the development project: The technology for the collection system needs to be developed as a prototype. When it's developed the prototype will be fitted to Yanmar's net cleaner that will be modified for solid surfaces and connected to Optimarin's technology for filter and UV treatment. The cleaning speed is about 1500m2 per hour and is using water pressure in three rotating disks for cleaning the surfaces. iCsys AS will be engaged with implementing sensors and creating unique 3D-mapping software. iCsys will also implement autonomic features for the unit. Regarding research and documentation, we will involve Christian Michelsen Research AS that will document the effectiveness of the finalized unit. Østerbø Maskin will assist with CAD, engineering, and manufacturing of the unit.CSI intends to apply for Innovation Norway's Environmental technology program to start the development of this unit, thus searching for companies or investors willing to finance this project.

Urban Infrastructure Partner is a Norwegian based mobility operator and in 2016  we launched a new kind of bike sharing- Oslo City Bike, which has more than doubled usage in less than 8 months. In Oslo we’ve now reached more than 2 million trips and increased the utilization to 10 trips per bike per day. But most importantly - we make mobility more efficient and easier for a lot of people every day.We believe success for a smart city and systems like ours should not be measured by it's mere existence, but on the actual effect it has for the city.Read more about how it is to work with us here https://oslobysykkel.no/ansatte

WindTechVi er et tidlig fase prosjekt som jobber med utvikling av teknologi og risikostyringssystemer for kaldt klima. Vi jobber med en løsning på et identifisert problem, som vi ønsker å videre utvikle og kommersialisere. Her er de hovedaktivitetene som vi har gjennomført siden september 2016; - Prototype 1 simulering - Kommersiell vurdering - Markedsavklaring og forretningsutvikling - Pitche konkurranse (100’) - Styrket teamet med produktutvikler - VRI midler - Prototype 2 test i lab - Prototype 3 test i felt - Pre-inkubasjons avtale Veien videre - Styrke laget - Videre markedsavklaring og kontakt med industri - Forretningsutvikling og produktutvikling - Hente inn midler (IN – Markedsavklaring, FNY student ) - Etablere selskap Les mer på www.windtech.no Vi tar gjerne en prat med deg om du er interessert i å bli en del av WindTech Ta kontakt med Daniel Swart på 986 48 723 eller daniel@windtech.no